First-in-human Evaluation of [18F]CETO

Clinical trial NCT05361083 · COMPLETED

Trial details

NCT number: NCT05361083
Sponsor: Uppsala University
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Primary Aldosteronism Due to Aldosterone Producing Adenoma Primary Aldosteronism Due to Nodular Hyperplasia Adrenal Cushing Syndrome Non-Secretory Adrenal Adenoma Adrenocortical Carcinoma

Start date: 2019-09-01
Primary completion: 2021-04-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.